Invivo Therapeutics Holdings Corp (NVIV) |
|
0.5895 -0.011 (-1.75%)
|
10-23 22:42 |
|
Open: |
0.62 |
Pre. Close: |
0.6 |
|
High:
|
0.62 |
Low:
|
0.57 |
|
Volume:
|
3,991,742 |
Market Cap:
|
3M |
|
|
|
|
InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company. The Company is engaged in developing and commercializing biopolymer-scaffolding devices for the treatment of spinal cord injuries (SCI). The Company's approach to treating acute SCIs is based on its investigational Neuro Spinal Scaffold implant, an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord contusion and is intended to treat acute spinal cord injury. The Neuro-Spinal Scaffold consists of biocompatible and bioresorbable polymers, which include poly lactic-co-glycolic acid (PLGA) and Poly-L-Lysine (PLL). The Company is also evaluating other technologies and therapeutics that may be complementary to its development of the Neuro-Spinal Scaffold implant. The Company has a clinical development program for acute SCI and a preclinical development program for chronic SCI. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.624 - 0.63 |
0.63 - 0.634 |
|
Low:
|
0.558 - 0.565 |
0.565 - 0.57 |
|
Close:
|
0.581 - 0.594 |
0.594 - 0.601 |
|
Technical analysis |
as of: 2020-10-23 4:47:21 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 1.34 One year: 1.75 |
| Support: |
Support1: 0.57 Support2: 0.47 |
| Resistance: |
Resistance1: 1.14 Resistance2: 1.50 |
| Pivot: |
1.26  |
| Moving Average: |
MA(5): 0.98 MA(20): 1.29
MA(100): 1.49 MA(250): 3.66 |
| MACD: |
MACD(12,26): -0.13 Signal(9): -0.05 |
| Stochastic oscillator: |
%K(14,3): 9.02 %D(3): 10.05 |
| RSI: |
RSI(14): 15.63 |
| 52-week: |
High: 16.20 Low: 0.57 Change(%): -95.6 |
| Average Vol(K): |
3-Month: 46458 10-Days: 221449 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.NVIV has closed below the lower band by 11.6%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 195.9% wider than normal. The large width of the bands suggest high volatility as compared to NVIV's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Fri, 23 Oct 2020
The Daily Biotech Pulse: Gilead Gets Full Approval For Remdesivir, Akebia's Positive Readout, Foghorn IPO - Benzinga
Fri, 23 Oct 2020
The Forecast Just Changed on InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) - The Oracle Dispatch
Thu, 22 Oct 2020
InVivo Therapeutics Holdings Corp. (NVIV) Plunges 47.33% on October 22 - Equities.com
Thu, 22 Oct 2020
Boiling and ready to burst as InVivo Therapeutics Holdings Corp. (NVIV) last month performance was -18.04% - The InvestChronicle
Thu, 22 Oct 2020
Mid-Day Market Update: Crude Oil Rises 2%; InVivo Therapeutics Shares Plummet - Benzinga
Thu, 22 Oct 2020
Is There a Dimmer Outlook Ahead for InVivo Therapeutics Holdings Corp. (NVIV)? - The News Heater
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
n/a |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Underperform |
Price to Earnings: |
Underperform |
| Return on Equity: |
Underperform |
Debt to Equity: |
Neutral |
|
